Kern v. Arlington Ridge Pathology, S.C.

CourtAppellate Court of Illinois
DecidedAugust 7, 2008
Docket1-07-2615 Rel
StatusPublished

This text of Kern v. Arlington Ridge Pathology, S.C. (Kern v. Arlington Ridge Pathology, S.C.) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kern v. Arlington Ridge Pathology, S.C., (Ill. Ct. App. 2008).

Opinion

FOURTH DIVISION August 7, 2008

No. 1-07-2615

SUSAN B. KERN, ) Appeal from the ) Circuit Court of Plaintiff-Appellant, ) Cook County, Illinois. ) v. ) No. 05 CH 18394 ) ARLINGTON RIDGE PATHOLOGY, S.C., and ) RICHARD REGAN, ) Honorable James F. Henry, ) Judge Presiding. Defendants-Appellees. )

JUSTICE MURPHY delivered the opinion of the court:

Plaintiff, Susan B. Kern, M.D., brought an action on October 27, 2005, seeking an

injunction against the action of defendant, Richard Regan, M.D. (Regan), and Arlington Ridge

Pathology, S.C. (Arlington). The Arlington board of directors with Regan as president of the

board amended Arlington’s articles of incorporation (articles) on October 21, 2005, to be

effective on October 26, 2005. The amendment modified the percentage of shareholder votes

required to amend or alter Arlington’s corporate bylaws. On October 26, 2005, Regan issued

notice of a special meeting and proposed changes to the bylaws. Plaintiff later amended her

complaint for injunctive relief by adding counts for breach of fiduciary duty and conspiracy. On

January 18, 2007, the trial court granted defendants’ motion for summary judgment, finding that

the board legally amended the articles. 1-07-2615

On appeal, plaintiff asserts several grounds in support of her argument for reversal.

Plaintiff argues that the trial court erred in its interpretations of the bylaws and the Business

Corporation Act of 1983 (Act) (805 ILCS 5/1 et seq. (West 2004)) in finding a proper quorum

existed to allow amendment of the articles. Plaintiff contends that, as a beneficiary of the

amendment, Regan had the burden, but failed, to show the transaction was fair and in good faith.

Plaintiff also asserts that questions of material fact remain on all counts because various issues

were not sufficiently addressed in affidavits and other evidentiary submissions. For the following

reasons, we affirm the holding of the trial court.

I. BACKGROUND

On March 1, 1994, Arlington was incorporated under the laws of the State of Illinois for

the purpose of the study, diagnosis and treatment of human ailments and injuries. Plaintiff and

Kishen Manglani, M.D. (Manglani), were among the original six pathologists that were

shareholders in Arlington. Arlington maintained an exclusive services agreement with Northwest

Community Hospital (Northwest) in Arlington Heights, Illinois. Arlington’s offices are located in

the Northwest facilities and plaintiff performed her duties at this location.

On January 11, 2000, plaintiff was elected vice president and secretary of the board. In

2002, Regan was admitted as a shareholder. Regan later became president for the relevant

transactions of October 2005. In 2005, only plaintiff, Regan, and Manglani remained as

shareholders of Arlington, holding 166, 170, and 166 shares, respectively. Plaintiff, Regan, and

Manglani were also the only directors during the relevant times.

The articles do not contain provisions regarding the configuration of the board or quorum

requirements for the board to transact business. Section 3.2 of the bylaws, the variable range

-2- 1-07-2615

requirement, provides that the board shall consist of between four and nine directors, each of

whom is required to be a licensed physician and shareholder employee of Arlington. Section 3.9

of the bylaws sets a quorum for the transaction of business as a majority of the directors, except

where provided otherwise.

The articles are also silent on the requirements for board actions and the bylaws again

provide guidance. Under section 3.3(b) of the bylaws, with notice that a meeting will be held to

vote on the removal of a director, the board may remove a director with the vote of 80% of

outstanding shares. Section 9.3 of the bylaws requires a vote of persons holding at least 67% of

outstanding shares for any of several listed “Major Decisions” to be valid. Included among the

major decisions are amending or modifying the bylaws and several decisions with financial

implications. However, Article XIV of the bylaws provides, “[e]xcept to the extent otherwise

provided in the Articles of Incorporation, these bylaws shall be subject to alteration, amendment

or repeal, and new bylaws may be adopted only by the affirmative vote of persons holding eighty

percent (80%) of outstanding shares of the Corporation.”

Despite the variable range requirement, outside of a period of time in 2002, Arlington has

operated with a three-person board since 1999. Plaintiff stated in her supporting affidavits that

during this period, there were no regular or annual board meetings, the bylaws were never

amended by the board, and only two special meetings of the board were called in 2000.

Furthermore, all actions of the board were by unanimous vote of the three board members. These

actions included the election of plaintiff as vice president and secretary, setting the value of a

retirement gift for a shareholder physician, and actions regarding Arlington’s pension and profit-

sharing plans.

Also during this time, plaintiff alleges that a dispute arose between her and Bruce

-3- 1-07-2615

Crowther, chief executive officer of Northwest. Plaintiff was elected president of the Northwest

medical staff in 2001. Plaintiff alleged that her relationship with Crowther was always strained

and that it grew contentious in a dispute regarding Northwest’s use of hospitalist physicians.

Plaintiff alleges that she subsequently was the victim of verbal abuse by Crowther. In response,

plaintiff filed an incident report with Northwest’s board of directors on September 12, 2001.

Plaintiff alleges that since that time, Crowther harbored ill-will and animus against her and

sought revenge. Although not of record, and allegedly was never made available to plaintiff, an

Arlington employee who had been disciplined by Arlington for conduct detrimental to the

corporation filed an occurrence report with Northwest in or around June 2005. The report

included accusations that plaintiff acted inappropriately and unprofessionally in expressing

Arlington’s dissatisfaction with the employee. In response, plaintiff alleges that Northwest

conducted a “circus investigation.” In August 2005, Crowther met with Regan, who asserted the

issue was an internal matter for Arlington to handle.

In order to avoid the due process and procedural rights afforded plaintiff under

Northwest’s grievance procedure, plaintiff claims that Northwest decided to exercise its rights

under its agreement with Arlington. Crowther issued a letter to Regan on August 24, 2005,

outlining the occurrence report and investigation of plaintiff. Crowther indicated that plaintiff

exhibited threatening and abusive behavior and created a hostile work environment. Accordingly,

pursuant to the agreement between the parties, Crowther threatened to terminate Arlington’s

exclusive services agreement if plaintiff was not sent to professional counseling or if her

employment with Arlington was not terminated.

Plaintiff alleges that she was informed that Crowther and Regan discussed the necessity of

manipulating Arlington’s articles and bylaws to allow for plaintiff’s termination. On October 17,

-4- 1-07-2615

2005, Regan issued notice of a special board meeting on October 21, 2005, at 1:30 p.m., that did

not include an agenda or stated purpose.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Marsaw v. Richards
857 N.E.2d 794 (Appellate Court of Illinois, 2006)
Adames v. Sheahan
880 N.E.2d 559 (Appellate Court of Illinois, 2007)
Babich v. River Oaks Toyota
879 N.E.2d 420 (Appellate Court of Illinois, 2007)
Wells v. Minor
578 N.E.2d 1337 (Appellate Court of Illinois, 1991)
Langer v. Becker
531 N.E.2d 830 (Appellate Court of Illinois, 1988)
First Church of Deliverance v. Holcomb
502 N.E.2d 298 (Appellate Court of Illinois, 1986)
Kim v. Citigroup, Inc.
856 N.E.2d 639 (Appellate Court of Illinois, 2006)
Somers v. AAA Temporary Services, Inc.
284 N.E.2d 462 (Appellate Court of Illinois, 1972)
Weiss Medical Complex, Ltd. v. Kim
408 N.E.2d 959 (Appellate Court of Illinois, 1980)
In Re Estate of Vogel
684 N.E.2d 1035 (Appellate Court of Illinois, 1997)
Abreu v. Unica Industrial Sales, Inc.
586 N.E.2d 661 (Appellate Court of Illinois, 1991)
Cratty v. Peoria Law Library Ass'n
76 N.E. 707 (Illinois Supreme Court, 1906)
Bay City Lumber Co. v. Anderson
111 P.2d 771 (Washington Supreme Court, 1941)
Johnson v. Sengstacke
79 N.E.2d 761 (Appellate Court of Illinois, 1948)

Cite This Page — Counsel Stack

Bluebook (online)
Kern v. Arlington Ridge Pathology, S.C., Counsel Stack Legal Research, https://law.counselstack.com/opinion/kern-v-arlington-ridge-pathology-sc-illappct-2008.